Literature DB >> 23553243

Incidence and clinical characteristics of prelaryngeal lymph node metastasis in papillary thyroid cancer.

Young Chan Lee1, Seung Youp Shin, Kee Hwan Kwon, Young Gyu Eun.   

Abstract

There is little data that determine the clinical characteristics of prelaryngeal lymph nodes (PLN) metastasis in patients with papillary thyroid cancer (PTC). The aims of this prospective study were to evaluate the incidence and the clinical characteristics of metastasis to the PLN for PTC patients who underwent total thyroidectomy and prophylactic central neck dissection. Sixty-seven patients who underwent total thyroidectomy and prophylactic bilateral central lymph node neck dissection for PTC were enrolled. Central neck compartment was further divided into prelaryngeal, ipsilateral/contralateral paratracheal, and pretracheal regions. Clinicopathologic factors including age, sex, tumor size and location, extrathyroidal extension, and central and lateral nodal metastasis were evaluated. Of the 67 patients who underwent PLN dissection, 13 (19.4 %) had evidence of PLN metastasis. Tumor size was significantly larger in patients with PLN involvement (2.28 versus 1.12 cm; p = 0.020). Additionally, primary tumors larger than 1 cm, extrathyroidal extension, and isthmus involvement were more prevalent in PLN-positive patients. Patients with positive PLNs were also more frequently found to have lateral lymph node metastasis (23.1 vs. 1.9 %; p = 0.021), pretracheal lymph node metastasis (76.9 vs. 27.8 %; p = 0.003), and bilateral central lymph node metastasis (38.5 vs. 11.1 %; p = 0.031) than PTC patients without PLN involvement. The incidence of PLN metastasis in PTC patients who underwent prophylactic central lymph node neck dissection was 19.4 %. PLN metastasis was associated with tumor size, extrathyroidal extension, isthmus involvement, and other compartment lymph node metastasis.

Entities:  

Mesh:

Year:  2013        PMID: 23553243     DOI: 10.1007/s00405-013-2471-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

Review 1.  Prognostic value of Delphian lymph node metastasis from laryngeal and hypopharyngeal cancer.

Authors:  Alfio Ferlito; Ashok R Shaha; Alessandra Rinaldo
Journal:  Acta Otolaryngol       Date:  2002-06       Impact factor: 1.494

2.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

3.  Incidence and significance of Delphian node metastasis in papillary thyroid cancer.

Authors:  N Gopalakrishna Iyer; Anumeha Kumar; Iain J Nixon; Snehal G Patel; Ian Ganly; R Michael Tuttle; Jatin P Shah; Ashok R Shaha
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

4.  Delphian lymph node in laryngeal carcinoma: a whole organ study.

Authors:  E R Thaler; K Montone; J Tucker; G S Weinstein
Journal:  Laryngoscope       Date:  1997-03       Impact factor: 3.325

5.  Evaluation of cervical lymph node metastasis of 1400 patients with cancer of the larynx.

Authors:  J Tomik; J Składzien; M Modrzejewski
Journal:  Auris Nasus Larynx       Date:  2001-08       Impact factor: 1.863

Review 6.  Laryngeal cancer: diagnosis and preoperative work-up.

Authors:  Eugene A Chu; Young J Kim
Journal:  Otolaryngol Clin North Am       Date:  2008-08       Impact factor: 3.346

7.  Prognostic value of Delphian lymph node in T1b glottic carcinoma.

Authors:  Lorenzo Pignataro; Andrea Peri; Davide Pagani; Gabriele Scaramellini; Guido Broich
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

8.  The Delphian lymph node in thyroid cancer.

Authors:  Joseph D Isaacs; Catharina I Lundgren; Stan B Sidhu; Mark S Sywak; Pam J Edhouse; Leigh W Delbridge
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

9.  Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Won Woong Kim; Song I Yang; Jeong Hoon Kim; Young Sik Choi; Yo-Han Park; Su Kyoung Kwon
Journal:  World J Surg Oncol       Date:  2012-10-30       Impact factor: 2.754

10.  Prognostic value of the prelaryngeal node in laryngeal and hypopharyngeal carcinoma.

Authors:  L Resta; C Micheau; A Cimmino
Journal:  Tumori       Date:  1985-08-31
View more
  13 in total

1.  Thyroid cancer and Delphian node.

Authors:  Ashok R Shaha
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09       Impact factor: 2.503

2.  Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.

Authors:  Young Jun Chai; Su-Jin Kim; June Young Choi; Do Hoon Koo; Kyu Eun Lee; Yeo-Kyu Youn
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

3.  Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma.

Authors:  Eun Mee Oh; Yoo Seung Chung; Young Don Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

4.  Increasing thyroid cancer rate and the extent of thyroid surgery in Korea.

Authors:  Myung-Whun Sung; Bumjung Park; Soo-Youn An; J Hun Hah; Young Ho Jung; Hyo Geun Choi
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

5.  Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis.

Authors:  Guibin Zheng; Hua Zhang; Shaolong Hao; Chengxin Liu; Jie Xu; Jinyao Ning; Guochang Wu; Lixin Jiang; Guojun Li; Haitao Zheng; Xicheng Song
Journal:  Oncotarget       Date:  2017-07-06

6.  Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: a single-institution study, systemic review and meta-analysis.

Authors:  Bin Wang; Xing-Zhu Wen; Wei Zhang; Ming Qiu
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-08-30

7.  Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer.

Authors:  Xingchen Li; Yuansheng Duan; Dandan Liu; Hongwei Liu; Mengqian Zhou; Kai Yue; Yanjie Shuai; Yu Wang; Chenyan Ji; Chao Jing; Yansheng Wu; Xudong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-25       Impact factor: 5.555

8.  Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.

Authors:  Zunfu Ke; Yihao Liu; Yunjian Zhang; Jie Li; Ming Kuang; Sui Peng; Jinyu Liang; Shuang Yu; Lei Su; Lili Chen; Cong Sun; Bin Li; Jessica Cao; Weiming Lv; Haipeng Xiao
Journal:  Oncol Rep       Date:  2018-06-14       Impact factor: 3.906

9.  Clinical Study on Prelaryngeal Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Authors:  Jin-Xing Gong; Jian-Wei Gu; Feng Ji; Kun Li; Qi Zhu; Fang-Ying Gu; Yan Chen; Qing-Hai Ji
Journal:  Cancer Manag Res       Date:  2020-02-21       Impact factor: 3.989

10.  Isthmic Papillary Thyroid Carcinoma Presents a Unique Pattern of Central Lymph Node Metastasis.

Authors:  Liguang Zhou; Chao Gao; Haipeng Li; Weili Liang; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.